Should Healthcare Professionals Be Allowed to Use Cannabis?Should Healthcare Professionals Be Allowed to Use Cannabis?
Drug Diversion Insights with Terri Vidals
Healthcare experts discuss whether nurses and other safety-sensitive professionals should use cannabis, focusing on impairment, legality and patient safety. The conversation raises complex questions about workplace testing, medical marijuana cards and how monitoring programmes currently address THC use.
43:44•26 Aug 2026
Cannabis, Nurses and Patient Safety: Tough Questions for Healthcare Leaders
Episode Overview
- Cannabis is repeatedly described as an impairing substance that can affect decision-making, memory, attention and emotional processing in safety-sensitive roles.
- Facilities often avoid THC testing due to fears about staffing and legal complications around medical marijuana cards, despite liability risks.
- State-level legalisation and medical cards do not remove federal illegality or professional expectations to avoid impaired practice.
- Abstinence-based monitoring programmes for nurses currently treat cannabis similarly to alcohol, requiring a substance-free approach to protect patients.
- Research cited in the discussion shows increased accidents, injuries and absenteeism linked to cannabis use, raising concerns for healthcare settings.
“"We're still talking about an impairing substance and the risk to the patients."”
What drives someone to seek a life without impairing substances while still working in high‑stakes healthcare roles? This conversation zeroes in on that tension, focusing specifically on cannabis use among nurses and other safety‑sensitive professionals. Pharmacist and host Terri Vidals brings back Abby Migliore, COO of the Intervention Project for Nurses (IPN), and Shannon Opie, IPN’s CEO, to unpack why many healthcare facilities have strong diversion monitoring for controlled drugs yet seem to sidestep THC.
Terri points out that some organisations "choose not to test, probably because they don't want to know, or they're afraid they won't have any staff left," and asks the guests what they’re really seeing. Abby walks through the fast shift in US cannabis laws and the legal grey zones created by medical marijuana cards and state versus federal rules.
She highlights research showing that cannabis is an impairing substance affecting decision‑making, memory, attention and emotional processing, particularly worrying for anyone at the bedside. A standout study from Colorado showed reduced brain activity in heavy and recent cannabis users during working memory tasks, which raises serious questions about clinical safety.
Shannon repeatedly brings the discussion back to patient harm and liability, stressing that legality doesn’t equal safety: "We're still talking about an impairing substance and the risk to the patients." She shares examples of positive THC tests in nurses, many without medical cards, and the challenge of separating occasional use from chronic dependence when both can be risky in practice.
You’ll hear frank talk about drug testing, medical marijuana cards, changing DEA scheduling, and how abstinence‑based monitoring programmes currently treat cannabis alongside alcohol and other mood‑altering substances. The episode doesn’t hand out simple answers, but it gives healthcare leaders and recovering professionals plenty of real‑world data and tough questions to ponder. If you work in healthcare or support people in recovery, how would you balance staff retention, legality and genuine patient safety around cannabis use?
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.